Certified by Founder Lodge
ImmuneBridge
United States - San Francisco, California
START UP
1 Disclosed Funding Rounds $12,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ImmuneBridge is developing allogeneic immunotherapies for cancer. Our core technology drives the expansion of cord blood derived immune stem cells and establishes a novel, flexible, consisten
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 13 ,2023 | Seed | $12,000,000 |
Insight Partners
M Ventures
One Way Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
KarmaCheck | $45,000,000 | (Jun 28, 2024)
authentica solutions | $6,200,000 | (Jun 28, 2024)
Pear Commerce | $10,000,000 | (Jun 28, 2024)
Odaseva | $54,000,000 | (Jun 28, 2024)
Synthpop - Healthcare AI | $5,600,000 | (Jun 28, 2024)
